{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["an analogue of resveratrol", "insulin sensitivity", "metabolic health", "piceatannol"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29057795", "DateCompleted": {"Year": "2018", "Month": "06", "Day": "18"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "18"}], "Language": ["eng"], "ELocationID": ["1142", "10.3390/nu9101142"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "9", "Issue": "10", "PubDate": {"Year": "2017", "Month": "Oct", "Day": "18"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "The Effect of Piceatannol from Passion Fruit (Passiflora edulis) Seeds on Metabolic Health in Humans.", "Abstract": {"AbstractText": ["Animal studies have shown the beneficial effects of piceatannol on metabolic health; however, there is a lack of human studies designed to examine these effects. The objective of this study was to investigate the effects of piceatannol on metabolic health in humans. This randomized, placebo-controlled study was conducted on 39 subjects, including 10 overweight men and 9 overweight women (BMI \u2265 25), as well as 10 non-overweight men and 10 non-overweight women (BMI < 25). Subjects received piceatannol (20 mg/day) or placebo capsules for eight weeks in a random order. The primary outcome was the effect of piceatannol on glucose-metabolism, including insulin sensitivity. The secondary outcomes were the effects on other parameters, including blood pressure (BP), heart rate (HR), endothelial function, lipids, inflammation, oxidative stress, mood status, and Sirt1 and phospho-AMP-activated kinase (p-AMPK) expression in isolated peripheral blood mononuclear cells (PBMNCs). Supplementation with piceatannol in overweight men reduced serum insulin levels, HOMA-IR, BP and HR. Other groups, including non-overweight men, as well as overweight and non-overweight women, showed no beneficial effects on insulin sensitivity, BP and HR. Furthermore, piceatannol is not associated with other data, including body weight (BW), body composition, endothelial function, lipids, inflammation, oxidative stress, mood status, and Sirt1/p-AMPK expression in PBMNCs. In conclusion, supplementation with piceatannol can improve metabolic health, including insulin sensitivity, BP and HR, in overweight men."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. kitta@kanazawa-med.ac.jp."}, {"Identifier": [], "Affiliation": "Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. kitta@kanazawa-med.ac.jp."}], "LastName": "Kitada", "ForeName": "Munehiro", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. namu1192@kanazawa-med.ac.jp."}], "LastName": "Ogura", "ForeName": "Yoshio", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research and Development Department, Health and Wellness Headquarters, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama 230-8504, Japan. h-uchida-ji@morinaga.co.jp."}], "LastName": "Maruki-Uchida", "ForeName": "Hiroko", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research and Development Department, Health and Wellness Headquarters, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama 230-8504, Japan. m.sai@miobs.com."}], "LastName": "Sai", "ForeName": "Masahiko", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. tsuzuki@kanazawa-med.ac.jp."}], "LastName": "Suzuki", "ForeName": "Taeko", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. kkanasaki@kanazawa-med.ac.jp."}, {"Identifier": [], "Affiliation": "Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. kkanasaki@kanazawa-med.ac.jp."}], "LastName": "Kanasaki", "ForeName": "Keizo", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Clinical Laboratory, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. yuna-h@kanazawa-med.ac.jp."}], "LastName": "Hara", "ForeName": "Yuna", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Clinical Laboratory, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. hi-seto@kanazawa-med.ac.jp."}], "LastName": "Seto", "ForeName": "Hiromi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. naipicrc@kanazawa-med.ac.jp."}], "LastName": "Kuroshima", "ForeName": "Yuka", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. imonno@kanazawa-med.ac.jp."}], "LastName": "Monno", "ForeName": "Itaru", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diabetology and Endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. koya0516@kanazawa-med.ac.jp."}, {"Identifier": [], "Affiliation": "Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. koya0516@kanazawa-med.ac.jp."}], "LastName": "Koya", "ForeName": "Daisuke", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Capsules"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "6KS3LS0D4F", "NameOfSubstance": "3,3',4,5'-tetrahydroxystilbene"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": [], "DescriptorName": "Capsules"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["drug effects"], "DescriptorName": "Energy Metabolism"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Health Status"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": [], "DescriptorName": "Japan"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["blood", "diagnosis", "drug therapy", "physiopathology"], "DescriptorName": "Overweight"}, {"QualifierName": ["chemistry"], "DescriptorName": "Passiflora"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": ["administration & dosage", "adverse effects", "isolation & purification"], "DescriptorName": "Stilbenes"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Kyowa Hakko Kirin, Taisho Toyama Pharmaceutical and Ono Pharmaceutical contributed to establishing the Division of Anticipatory Molecular Food Science and Technology. Hiroko Maruki-Uchida and Masahiko Sai are employed by Morinaga and Company Limited. Morinaga and Company Limited provided support in the form of salaries for authors HM-U and MS, and provided the capsules containing piceatannol and placebo with cellulose and other diluents, including packaging and labeling, but did not have any additional role in the data collection and analysis, and decision to publish."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Matsuzawa Y., Funahashi T., Nakamura T. The concept of metabolic syndrome: Contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 2011;18:629\u2013639. doi: 10.5551/jat.7922.", "ArticleIdList": ["10.5551/jat.7922", "21737960"]}, {"Citation": "Kirkland J.L. Translating advances from the basic biology of aging into clinical application. Exp. Gerontol. 2013;48:1\u20135. doi: 10.1016/j.exger.2012.11.014.", "ArticleIdList": ["10.1016/j.exger.2012.11.014", "PMC3543864", "23237984"]}, {"Citation": "Tchkonia T., Morbeck D.E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosla S., Jensen M.D., Kirkland J.L. Fat tissue, aging, and cellular senescence. Aging Cell. 2010;9:667\u2013684. doi: 10.1111/j.1474-9726.2010.00608.x.", "ArticleIdList": ["10.1111/j.1474-9726.2010.00608.x", "PMC2941545", "20701600"]}, {"Citation": "Garcia-Prieto C.F., Fernandez-Alfonso M.S. Caloric Restriction as a Strategy to Improve Vascular Dysfunction in Metabolic Disorders. Nutrients. 2016;8:370. doi: 10.3390/nu8060370.", "ArticleIdList": ["10.3390/nu8060370", "PMC4924211", "27314388"]}, {"Citation": "Larson-Meyer D.E., Heilbronn L.K., Redman L.M., Newcomer B.R., Frisard M.I., Anton S., Smith S.R., Alfonso A., Ravussin E. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006;29:1337\u20131344. doi: 10.2337/dc05-2565.", "ArticleIdList": ["10.2337/dc05-2565", "PMC2677812", "16732018"]}, {"Citation": "Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337\u2013342. doi: 10.1038/nature05354.", "ArticleIdList": ["10.1038/nature05354", "PMC4990206", "17086191"]}, {"Citation": "Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109\u20131122. doi: 10.1016/j.cell.2006.11.013.", "ArticleIdList": ["10.1016/j.cell.2006.11.013", "17112576"]}, {"Citation": "Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., Swindell W.R., Kamara D., Minor R.K., Perez E., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157\u2013168. doi: 10.1016/j.cmet.2008.06.011.", "ArticleIdList": ["10.1016/j.cmet.2008.06.011", "PMC2538685", "18599363"]}, {"Citation": "Sun C., Zhang F., Ge X., Yan T., Chen X., Shi X., Zhai Q. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007;6:307\u2013319. doi: 10.1016/j.cmet.2007.08.014.", "ArticleIdList": ["10.1016/j.cmet.2007.08.014", "17908559"]}, {"Citation": "Szkudelski T., Szkudelska K. Resveratrol and diabetes: From animal to human studies. Biochim. Biophys. Acta. 2015;1852:1145\u20131154. doi: 10.1016/j.bbadis.2014.10.013.", "ArticleIdList": ["10.1016/j.bbadis.2014.10.013", "25445538"]}, {"Citation": "Timmers S., Konings E., Bilet L., Houtkooper R.H., van de Weijer T., Goossens G.H., Hoeks J., van der Krieken S., Ryu D., Kersten S., et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14:612\u2013622. doi: 10.1016/j.cmet.2011.10.002.", "ArticleIdList": ["10.1016/j.cmet.2011.10.002", "PMC3880862", "22055504"]}, {"Citation": "Kershaw J., Kim K.H. The Therapeutic Potential of Piceatannol, a Natural Stilbene, in Metabolic Diseases: A Review. J. Med. Food. 2017;20:427\u2013438. doi: 10.1089/jmf.2017.3916.", "ArticleIdList": ["10.1089/jmf.2017.3916", "PMC5444415", "28387565"]}, {"Citation": "Rodr\u00edguez-Cabo T., Rodr\u00edguez I., L\u00f3pez P., Ramil M., Cela R. Investigation of liquid chromatography quadrupole time-of-flight mass spectrometry performance for identification and determination of hydroxylated stilbene antioxidants in wine. J. Chromatogr. A. 2014;1337:162\u2013170. doi: 10.1016/j.chroma.2014.02.058.", "ArticleIdList": ["10.1016/j.chroma.2014.02.058", "24630056"]}, {"Citation": "Matsui Y., Sugiyama K., Kamei M., Takahashi T., Suzuki T., Katagata Y., Ito T. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J. Agric. Food Chem. 2010;58:11112\u201311118. doi: 10.1021/jf102650d.", "ArticleIdList": ["10.1021/jf102650d", "20822151"]}, {"Citation": "Kawakami S., Kinoshita Y., Maruki-Uchida H., Yanae K., Sai M., Ito T. Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients. 2014;6:4794\u20134804. doi: 10.3390/nu6114794.", "ArticleIdList": ["10.3390/nu6114794", "PMC4245563", "25360511"]}, {"Citation": "Sano S., Sugiyama K., Ito T., Katano Y., Ishihata A. Identification of the strong vasorelaxing substance scirpusin B, a dimer of piceatannol, from passion fruit (Passiflora edulis) seeds. J. Agric. Food Chem. 2011;59:6209\u20136213. doi: 10.1021/jf104959t.", "ArticleIdList": ["10.1021/jf104959t", "21526844"]}, {"Citation": "Kinoshita Y., Kawakami S., Yanae K., Sano S., Uchida H., Inagaki H., Ito T. Effect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells. Biochem. Biophys. Res. Commun. 2013;430:1164\u20131168. doi: 10.1016/j.bbrc.2012.12.017.", "ArticleIdList": ["10.1016/j.bbrc.2012.12.017", "23246837"]}, {"Citation": "Maruki-Uchida H., Kurita I., Sugiyama K., Sai M., Maeda K., Ito T. The protective effects of piceatannol from passion fruit (Passiflora edulis) seeds in UVB-irradiated keratinocytes. Biol. Pharm. Bull. 2013;36:845\u2013849. doi: 10.1248/bpb.b12-00708.", "ArticleIdList": ["10.1248/bpb.b12-00708", "23649341"]}, {"Citation": "Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., et al. Revised equations for estimated GFR from serum creatinine in Japan. J. Natl. Kidney Found. 2009;53:982\u2013992. doi: 10.1053/j.ajkd.2008.12.034.", "ArticleIdList": ["10.1053/j.ajkd.2008.12.034", "19339088"]}, {"Citation": "Imatoh T., Kamimura S., Tanihara S. Moderate oxidative stress and high antioxidative activity are associated with steatosis in Japanese males. Clin. Transl. Sci. 2013;6:45\u201349. doi: 10.1111/cts.12007.", "ArticleIdList": ["10.1111/cts.12007", "PMC5414532", "23399089"]}, {"Citation": "Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002;39:257\u2013265. doi: 10.1016/S0735-1097(01)01746-6.", "ArticleIdList": ["10.1016/S0735-1097(01)01746-6", "11788217"]}, {"Citation": "Shigiyama F., Kumashiro N., Miyagi M., Ikehara K., Kanda E., Uchino H., Hirose T. Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study. Cardiovasc. Diabetol. 2017;16:84. doi: 10.1186/s12933-017-0564-0.", "ArticleIdList": ["10.1186/s12933-017-0564-0", "PMC5500953", "28683796"]}, {"Citation": "Kitada M., Kume S., Takeda-Watanabe A., Tsuda S., Kanasaki K., Koya D. Calorie restriction in overweight males ameliorates obesity-related metabolic alterations and cellular adaptations through anti-aging effects, possibly including AMPK and SIRT1 activation. Biochim. Biophys. Acta. 2013;1830:4820\u20134827. doi: 10.1016/j.bbagen.2013.06.014.", "ArticleIdList": ["10.1016/j.bbagen.2013.06.014", "23800577"]}, {"Citation": "Matsumoto T., Asakura H., Hayashi T. Does lavender aromatherapy alleviate premenstrual emotional symptoms?: A randomized crossover trial. BioPsychoSoc. Med. 2013;7 doi: 10.1186/1751-0759-7-12.", "ArticleIdList": ["10.1186/1751-0759-7-12", "PMC3674979", "23724853"]}, {"Citation": "Yokoyama K. POMS Shortened Version. Kaneko Shobo; Tokyo, Japan: 2015. (In Japanese)"}, {"Citation": "Price D.D., Bush F.M., Long S., Harkins S.W. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994;56:217\u2013226. doi: 10.1016/0304-3959(94)90097-3.", "ArticleIdList": ["10.1016/0304-3959(94)90097-3", "8008411"]}, {"Citation": "Uchida-Maruki H., Inagaki H., Ito R., Kurita I., Sai M., Ito T. Piceatannol lowers the blood glucose level in diabetic mice. Biol. Pharm. Bull. 2015;38:629\u2013633. doi: 10.1248/bpb.b15-00009.", "ArticleIdList": ["10.1248/bpb.b15-00009", "25832644"]}, {"Citation": "Minakawa M., Miura Y., Yagasaki K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem. Biophys. Res. Commun. 2012;422:469\u2013475. doi: 10.1016/j.bbrc.2012.05.017.", "ArticleIdList": ["10.1016/j.bbrc.2012.05.017", "22579688"]}, {"Citation": "Zhang A.J., Rimando A.M., Mizuno C.S., Mathews S.T. alpha-Glucosidase inhibitory effect of resveratrol and piceatannol. J. Nutr. Biochem. 2017;47:86\u201393. doi: 10.1016/j.jnutbio.2017.05.008.", "ArticleIdList": ["10.1016/j.jnutbio.2017.05.008", "28570943"]}, {"Citation": "Tang Y.L., Chan S.W. A review of the pharmacological effects of piceatannol on cardiovascular diseases. Phytother. Res. 2014;28:1581\u20131588. doi: 10.1002/ptr.5185.", "ArticleIdList": ["10.1002/ptr.5185", "24919577"]}, {"Citation": "Yamamoto T., Li Y., Hanafusa Y., Yeh Y.S., Maruki-Uchida H., Kawakami S., Sai M., Goto T., Ito T., Kawada T. Piceatannol exhibits anti-inflammatory effects on macrophages interacting with adipocytes. Food Sci. Nutr. 2017;5:76\u201385. doi: 10.1002/fsn3.366.", "ArticleIdList": ["10.1002/fsn3.366", "PMC5217925", "28070318"]}, {"Citation": "Gimbrone M.A., Jr., Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016;118:620\u2013636. doi: 10.1161/CIRCRESAHA.115.306301.", "ArticleIdList": ["10.1161/CIRCRESAHA.115.306301", "PMC4762052", "26892962"]}, {"Citation": "Frombaum M., Therond P., Djelidi R., Beaudeux J.L., Bonnefont-Rousselot D., Borderie D. Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress. Free Radic. Res. 2011;45:293\u2013302. doi: 10.3109/10715762.2010.527337.", "ArticleIdList": ["10.3109/10715762.2010.527337", "21235286"]}, {"Citation": "Nguyen M.C., Ryoo S. Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice. Korean J. Physiol. Pharmacol. 2017;21:83\u201390. doi: 10.4196/kjpp.2017.21.1.83.", "ArticleIdList": ["10.4196/kjpp.2017.21.1.83", "PMC5214914", "28066144"]}, {"Citation": "Jeong S.O., Son Y., Lee J.H., Cheong Y.K., Park S.H., Chung H.T., Pae H.O. Resveratrol analog piceatannol restores the palmitic acid-induced impairment of insulin signaling and production of endothelial nitric oxide via activation of anti-inflammatory and antioxidative heme oxygenase-1 in human endothelial cells. Mol. Med. Rep. 2015;12:937\u2013944. doi: 10.3892/mmr.2015.3553.", "ArticleIdList": ["10.3892/mmr.2015.3553", "PMC4438933", "25815690"]}, {"Citation": "Verberne A.J., Stornetta R.L., Guyenet P.G. Properties of C1 and other ventrolateral medullary neurones with hypothalamic projections in the rat. Pt 2J. Physiol. 1999;517:477\u2013494. doi: 10.1111/j.1469-7793.1999.0477t.x.", "ArticleIdList": ["10.1111/j.1469-7793.1999.0477t.x", "PMC2269350", "10332096"]}, {"Citation": "Ma H.J., Cao Y.K., Liu Y.X., Wang R., Wu Y.M. Microinjection of resveratrol into rostral ventrolateral medulla decreases sympathetic vasomotor tone through nitric oxide and intracellular Ca2+ in anesthetized male rats. Acta Pharmacol. Sin. 2008;29:906\u2013912. doi: 10.1111/j.1745-7254.2008.00827.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00827.x", "18664323"]}, {"Citation": "Hijona E., Aguirre L., P\u00e9rez-Matute P., Villanueva-Mill\u00e1n M.J., Mosqueda-Solis A., Hasnaoui M., Nepveu F., Senard J.M., Bujanda L., Ald\u00e1miz-Echevarr\u00eda L., et al. Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: Gut microbiota, metabolic, endocrine, and cardiac aspects. J. Physiol. Biochem. 2016;72:567\u2013582. doi: 10.1007/s13105-015-0464-2.", "ArticleIdList": ["10.1007/s13105-015-0464-2", "26792656"]}, {"Citation": "Tung Y.C., Lin Y.H., Chen H.J., Chou S.C., Cheng A.C., Kalyanam N., Ho C.T., Pan M.H. Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota. Molecules. 2016;21:1419. doi: 10.3390/molecules21111419.", "ArticleIdList": ["10.3390/molecules21111419", "PMC6273354", "27792146"]}]}], "History": [{"Year": "2017", "Month": "8", "Day": "29"}, {"Year": "2017", "Month": "9", "Day": "22"}, {"Year": "2017", "Month": "10", "Day": "12"}, {"Year": "2017", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29057795", "PMC5691758", "10.3390/nu9101142", "nu9101142"]}}]}